ArticleTranslational andrology and urology2026
Clinical implication of immune check point inhibitors in advanced prostate cancer: insight from the KEYNOTE-991 trial.
Yasutaka YamadaPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ArticleTranslational andrology and urology2026
Yasutaka YamadaPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.